• Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$9.5m

Series A

$18.0m

Series B
*

N/A

Acquisition
Total Funding$27.5m

Recent News about Noblegen

Edit
More about Noblegeninfo icon
Edit

Noblegen is a pioneering life sciences company dedicated to creating sustainable solutions that challenge conventional practices. The company operates in the biotechnology sector, focusing on innovative products that have a positive impact on both human health and the environment. Noblegen serves a diverse range of clients, including food and beverage manufacturers, health and wellness companies, and other industries seeking sustainable alternatives. The business model revolves around leveraging its proprietary Euglena-based technology to develop and commercialize groundbreaking products. Revenue is generated through the sale of these innovative solutions and through strategic partnerships and collaborations.

Noblegen's market is global, targeting industries that are increasingly prioritizing sustainability and health. The company's unique approach involves questioning norms and taking non-linear paths to solve complex global problems. This strategy not only sets them apart but also accelerates the development of impactful solutions.

Keywords: biotechnology, sustainability, Euglena, palm oil replacement, vegan protein, innovation, health, environment, non-linear solutions, global impact.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.